FolioLanternBeta
BRVEBraveheart Bio, Inc.

Christopher Viehbacher

Director at Braveheart Bio, Inc., as of Aug 7, 2026In the past 12 months: bought $1.5M of stock in 1 open-market purchase.

Updated Oct 15, 2026 from SEC filings · covers Oct 14, 2025 to Oct 13, 2026
$1.5M
open-market purchases, past 12 months (1 trade)
2
companies filed for

Shares held at Braveheart Bio, Inc. is being verified and not shown yet. Why

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Braveheart Bio, Inc. (BRVE)DirectorAug 5, 2026Aug 7, 2026
Biogen (BIIB)President and CEO, DirectorNov 21, 2022Feb 17, 2026

Also a director at

Biogen (BIIB)

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.